Sherman Clinical Research
Sherman, Texas, United States
Doctor in Sherman, Texas
300 N Highland Ave, Sherman, TX 75092
About Sherman Clinical Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Phathom Pharmaceuticals, Inc.
2
Verona Pharma plc
2
Bellus Health Inc
1
Boehringer Ingelheim
1
Eli Lilly and Company
1
Enanta Pharmaceuticals, Inc
1
Genentech, Inc.
1
Inventiva Pharma
1
Janssen Research & Development, LLC
1
NewAmsterdam Pharma
1
Novartis Pharmaceuticals
1
Clinical Trials at Sherman Clinical Research
During the past decade, Sherman Clinical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus
2017-08-14
2019-05-06
Completed
302
A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
2020-01-22
2022-01-04
Completed
82
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
2020-09-29
2022-12-02
Completed
763
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
2020-09-22
2022-07-06
Completed
808
Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
2020-12-07
2021-11-02
Completed
310
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
2021-03-25
2022-01-17
Completed
458
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
2021-04-20
2024-07-30
Recruiting
700
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
2021-08-19
2026-09-30
Recruiting
1,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sherman Clinical Research" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 2 trials, followed by "Verona Pharma plc" with 2 trials
sponsored, "Bellus Health Inc" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sherman Clinical Research"
#1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Sherman Clinical Research
According to Clinical.Site data, the most researched conditions in "Sherman Clinical Research" are
"Chronic Obstructive Pulmonary Disease" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Heartburn" (2 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Sherman Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Sherman Clinical Research
Most popular intervention types in "Sherman Clinical Research" are "Drug" (13 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Ensifentrine" (2 trials), "Vonoprazan" (2 trials), "Astegolimab" (1 trials) and "BLU-5937" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sherman Clinical Research
The vast majority of trials in "Sherman Clinical Research" are
14 trials for "All" genders.
Clinical Trials Status at Sherman Clinical Research
Currently, there are NaN active trials in "Sherman Clinical Research".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Sherman Clinical Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sherman Clinical Research, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".